La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Carter Bankshares Bilan de santé

Santé financière contrôle des critères 4/6

Carter Bankshares possède un actif total de $4.5B et un capital total de $364.4M. Le total des dépôts est $3.9B et le total des prêts est $3.5B générant une marge d'intérêt nette de 2.9%. La provision pour créances douteuses est insuffisante, puisqu'elle représente actuellement 8.5% du total des prêts. Les liquidités et les placements à court terme représentent $81.3M.

Informations clés

12.4x

Ratio actifs/fonds propres

2.9%

Marge d'intérêt nette

Total des dépôts	US$3.88b
Ratio prêts/dépôts	Approprié
Prêts irrécouvrables	8.5%
Provision pour créances douteuses	Faible
Ratio de liquidité générale	Faible
Trésorerie et équivalents	US$81.34m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Analysts Just Made A Major Revision To Their Carter Bankshares, Inc. (NASDAQ:CARE) Revenue Forecasts

Aug 01

It Looks Like Carter Bankshares, Inc.'s (NASDAQ:CARE) CEO May Expect Their Salary To Be Put Under The Microscope

Jun 17

Would Shareholders Who Purchased Carter Bankshares' (NASDAQ:CARE) Stock Three Years Be Happy With The Share price Today?

Mar 05

How Much Are Carter Bankshares, Inc. (NASDAQ:CARE) Insiders Taking Off The Table?

Jan 28

Carter Bank inks agreement with Pendleton Community Bank

Jan 14

Carter Bank & Trust  EPS of -$2.19

Oct 29

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des institutions financières

Niveau d'actif: Le ratio actifs/capitaux propres de CARE ( 12.4 x) est modéré.

Provision pour créances douteuses: CARE a une faible provision pour créances douteuses ( 32 %).

Passifs à faible risque: 93% du passif de CARE est constitué principalement de sources de financement à faible risque.

Niveau de prêt: CARE a un niveau approprié de ratio prêts/actifs ( 76% ).

Dépôts à faible risque: Le ratio prêts/dépôts de CARE ( 89% ) est approprié.

Niveau des créances douteuses: CARE a un niveau élevé de créances douteuses ( 8.5 %).

Carter Bankshares Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Price target increased by 18% to US$20.00

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improves as stock rises 20%

Price target decreased by 12% to US$15.00

Consensus EPS estimates increase by 155%

Carter Bankshares, Inc., Annual General Meeting, May 22, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 27%, revenue downgraded

Carter Bankshares, Inc. Introduces Carter Zescrow

Consensus EPS estimates increase by 151%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.2% to US$15.25

Carter Bankshares, Inc. Reports Unaudited Net Charge Offs for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 18%

Analysts Just Made A Major Revision To Their Carter Bankshares, Inc. (NASDAQ:CARE) Revenue Forecasts

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Insider selling

High number of new directors

Price target decreased by 8.4% to US$18.08

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorates as stock falls 21%

Carter Bankshares, Inc. Reports Net Charge-Offs for the Fourth Quarter Ended December 31, 2022

Full year 2022 earnings released: EPS: US$2.04 (vs US$1.19 in FY 2021)

Carter Bankshares, Inc. Announces Executive Changes

Price target increased to US$21.00

Third quarter 2022 earnings released: EPS: US$0.59 (vs US$0.42 in 3Q 2021)

Carter Bankshares, Inc. Reports Net Charge-Offs for the Third Quarter Ended September 30, 2022

Consensus EPS estimates increase by 16%

Second quarter 2022 earnings released: EPS: US$0.44 (vs US$0.20 in 2Q 2021)

Price target decreased to US$17.83

First quarter 2022 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

An unknown buyer acquired 16 Branches of Carter Bankshares, Inc.

Independent Director recently bought US$90k worth of stock

Price target increased to US$17.25

Third quarter 2021 earnings released: EPS US$0.42 (vs US$2.19 loss in 3Q 2020)

Price target increased to US$16.75

Second quarter 2021 earnings released: EPS US$0.21 (vs US$0.17 in 2Q 2020)

It Looks Like Carter Bankshares, Inc.'s (NASDAQ:CARE) CEO May Expect Their Salary To Be Put Under The Microscope

Price target increased to US$15.92

First quarter 2021 earnings released: EPS US$0.36 (vs US$0.17 in 1Q 2020)

Price target increased to US$14.58

Carter Bankshares, Inc. Announces Retirement of Charles E. Hall as Director

Carter Bankshares, Inc., Annual General Meeting, Jun 23, 2021

Revenue beats expectations

Full year 2020 earnings released: US$1.74 loss per share (vs US$1.01 profit in FY 2019)

Would Shareholders Who Purchased Carter Bankshares' (NASDAQ:CARE) Stock Three Years Be Happy With The Share price Today?

New 90-day high: US$12.05

Full year 2020 earnings released: US$1.74 loss per share (vs US$1.01 profit in FY 2019)

Revenue beats expectations

Farmers & Merchants Bank agreed to acquire operations of Branch Office in Waynesboro, Virginia of Carter Bankshares, Inc.

How Much Are Carter Bankshares, Inc. (NASDAQ:CARE) Insiders Taking Off The Table?

Price target raised to US$12.58

New 90-day high: US$12.02

Carter Bank inks agreement with Pendleton Community Bank

New 90-day high: US$11.00

New 90-day high: US$10.01

Price target raised to US$10.17

Analysts lower EPS estimates to -US$1.75

New 90-day high: US$7.95

Third quarter 2020 earnings released: US$2.19 loss per share

Revenue and earnings miss expectations

Carter Bank &amp; Trust&nbsp; EPS of -$2.19

New 90-day low: US$6.83

First half earnings released

Price target lowered to US$9.25

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des institutions financières

Découvrir des entreprises saines

Carter Bank & Trust EPS of -$2.19